Skip to main content Skip to main navigation menu Skip to site footer
Articles
Published: 02-23-2022

Diagnóstico da Doença Inflamatória Intestinal na Criança e Adolescente

Assistente do Departamento de Gastroenterologia do Hospital das Clínicas da Universidade de São Paulo e Gastroenterologista Pediátrica da Clínica de Especialidades Pediátricas do Hospital Israelita Albert Einstein em São Paulo
inflammatory bowel disease diagnosis differential diagnosis

Abstract

The criteria of Porto1 is aligned with the presentation of ESPGHAN because both sources draw attention to the care that must be taken to make the diagnosis of Inflammatory Bowel Disease (IBD) in children and adolescents, but especially in children under 6 years old in order to exclude the possibility of primary immunodeficiencies and monogenic diseases. The presentation of ESPGHAN reinforces that is very important the way how we introduce the diagnosis to the family and pediatric patients with IBD. Professionals should, if possible, have a team specialized in pediatric IBD, a pediatrician, pediatric gastroenterologist, nurse, nutritionist, psychologist, etc. IBD has become an increasingly diagnosed in children of all ages. This condition has a particular clinical picture in children compared with adults. Perform early diagnosis is crucial to avoid an additional impact on the nutritional status, pondoestatural and pubertal development. It also requires attention to the consequences of IBD on the psychosocial aspect of children and adolescents, it is common to break school and social activities, especially in those patients with unstable or severe disease, requiring psychological intervention.

Metrics

Metrics Loading ...

References

  1. Levine A, Koletzko S, Turner D, Escher JC, Cucchiara S, de Ridder L et al. European Society of Pediatric Gastroenterology, Hepatology, and Nutrition. ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J.Pediatric Gastroenterol Nutr 2014; 58(6):795-806.
  2. de Bie CI, Buderus S, Sandhu BK, de Ridder L, Paerregaard A, Veres G et al. EUROKIDS Porto IBD Working Group of ESPGHAN. Diagnostic workup of paediatric patients with inflammatory bowel disease in Europe: results of a 5-year audit of the HYPERLINK “http://www.ncbi.nlm.nih.gov/pubmed/21857248”. J Pe-diatr Gastroenterol Nutr. 2012;54(3):374-80.
  3. Aurangzeb B, Leach St, Lemberg DA, Day AS. Assessment of Nutrition Status and Serum Leptin in Children with Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2011, 52(5):536-541.
  4. Costa COPC, Carrilho FJ, Nunes VS, Sipahi AM, Rodrigues M. A snapshot of the nutritional status of Crohn’s disease among adolescents in Brazil: a prospective cross-sectional study. BMC Gastroenterology 2015, 15:172
  5. Mason A, Malik S, McMillan M, McNeill JD, Bishop J, McGrogan P, Russel RK, Ahmed SF. A Prospective Longitudinal Study of Growth and Pubertal Progress in Adolescent with Inflammatory Bowel Disease. Hormone Research in Pediatrics 2015,83 (1):45-54.
  6. Baumgart DC, Sandborn HYPERLINK “http://www.ncbi.nlm.nih.gov/pubmed?term=%22Sandborn%20WJ%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract” WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet. 2007 12; 369(9573):1641-57.
  7. Jose FA, Heyman MB. Extraintestinal HYPERLINK “http://www.ncbi.nlm.nih.gov/pubmed/18223370?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=2” manifestations of inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2008; 46(2):124-33.
  8. Tanner, J.M. Growth at adolescence. 2nd.ed. Oxford: Blackwell Scientific, 1962.
  9. Holtman GA, Lisman-van Leeuwen Y, Reitsma JB, Berger MY. Noninvasive Tests for Inflammatory Bowel Disease: A Meta-analysis. Pediatrics 2016, 137(1): 1-11.
  10. Carroccio A, Iacono G, Cottone M, Di Prima L, Cartabellotta F, Cavataio F et al. Diagnostic accuracy of fecal HYPERLINK “http://www.ncbi.nlm.nih.gov/pubmed/12765980”. Clin Chem. 2003;49(6 ):861-7
  11. Tsampalieros “http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Pediatr+2011%3B+159%3A340-2”. 2011;159(2):340-2.
  12. Amre DK, Lu SE, Costea F, Seidman EG. Utility of serological markers in predicting the early occurrence of complications and surgery in pediatric Crohn’s disease patients. Am J Gastroenterol. 2006; 101(3):645-52.
  13. Sauer CG. Radiation exposure in children with inflammatory bowel disease. Curr Opin Pediatr. 2012;24 (5):621-626.
  14. Hammer MR, Podberesky DJ, Dillman JR. Multidetector computed tomographic and magnetic resonance enterography in children: state of the art. Radiol Clin North Am HYPERLINK “http://www.ncbi.nlm.nih.gov/pubmed/?term=Radiol+Clin+N+Am+2013%2C+51%3A615-636. 2013 ;51(4):615-36.
  15. El-Chammas K, Majeskie A, Simpson P, Sood M, Miranda A.Red Flags in Children with Chronic Abdominal Pain and Crohn’s Disease–A Single Center Experience. J Pediatr 2013;162:783-7.
  16. Uhlig HH, Schwerd T, Koletzko S, Shah N, Kammermeier J, Elkadri A, Ouahed J et al. IBD Study Group and NEOPICS. The Diagnosis Approach to Monogenic Very Early Onset Inflammatory Bowel Disease. Gastroenterology 2014, 147(5):990-1007.
  17. Bass JA, Friesen CA, Deasy AD, Neilan NA, Braken JM. Investigation of potential early histologic markers of pediatric inflammatory bowel disease. BMC Gastroenterology 2015, 15:129.
  18. Kelsen JR, Dawany N, Moran CJ, Petersen BS, Sarmady M, Sasson A, Pauly-Hubbard H et al. Exome sequencing analysis reveals variants in primary immunodeficiency genes in patients with very early onset inflammatory bowel disease. Gastroenterology 2015, 149(6):1415-24.
  19. Kammermeier J, Drury S, James CT, Dziubak R, Ocaka L, Elawad M, Beasles P et al. Target gene panel sequencing in children with very early onset inflammatory bowel disease- evaluation and prospective analysis. J Med Genet 2014, 51(11):748-55.

How to Cite

Rodrigues, M. (2022). Diagnóstico da Doença Inflamatória Intestinal na Criança e Adolescente. International Journal of Nutrology, 10(1), 281–293. https://doi.org/10.1055/s-0040-1705650